U.S. Markets closed

Regulus: 3Q Earnings Snapshot

SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Tuesday reported a loss of $5.4 million in its third quarter.

The San Diego-based company said it had a loss of 26 cents per share.

The biopharmaceutical company posted revenue of $18,000 in the period.

In the final minutes of trading on Tuesday, the company's shares hit 65 cents. A year ago, they were trading at $1.50.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS